SEC Company Response from Lineage Cell Therapeutics, Inc. (LCTX) (CIK 0000876343) (LCTX) — Aug 14, 2012
Lineage Cell Therapeutics, Inc. (LCTX) (CIK 0000876343)
Date: Aug. 14, 2012 · CIK: 0000876343 · Accession: 0001140361-12-037034
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-182964
Letter
Securities and Exchange Commission Re: BioTime, Inc. Amendment No. 1 to Registration Statement on Form S-3 File No. 333-182964
Dear Ms. Zukin:
This letter is in response to your comment letter concerning the above-referenced Registration Statement and is being submitted to you in connection with BioTime's filing of Amendment No. 1. A copy of the amendment, redlined to show changes, is also being provided for your reference.
Comment 1.
We have added a statement on the prospectus cover page and have modified the disclosure on page 27 of the prospectus to state that LifeMap Sciences is an underwriter with respect to the shares it is offering for sale.
Comment 2.
The consent of the accountants has been filed as Exhibit 23.1
Please direct all correspondence and communications with respect to the Registration Statement to the undersigned.
Very truly yours,
s/Richard S. Soroko
Show Raw Text
CORRESP
1
filename1.htm
formcorresp.htm
LAW OFFICES
THOMPSON, WELCH, SOROKO & GILBERT LLP
3950 CIVIC CENTER DRIVE, SUITE 300
SAN RAFAEL, CA 94903
(415) 448-5000
FACSIMILE
RICHARD S. SOROKO
(415) 448-5010
email: rsoroko@TWSGLAW.com
SAN FRANCISCO OFFICE
(415) 262-1200
August 14, 2012
Ms. Rose Zukin
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re:
BioTime, Inc.
Amendment No. 1 to Registration Statement on Form S-3
File No. 333-182964
Dear Ms. Zukin:
This letter is in response to your comment letter concerning the above-referenced Registration Statement and is being submitted to you in connection with BioTime's filing of Amendment No. 1. A copy of the amendment, redlined to show changes, is also being provided for your reference.
Comment 1.
We have added a statement on the prospectus cover page and have modified the disclosure on page 27 of the prospectus to state that LifeMap Sciences is an underwriter with respect to the shares it is offering for sale.
Comment 2.
The consent of the accountants has been filed as Exhibit 23.1
Please direct all correspondence and communications with respect to the Registration Statement to the undersigned.
Very truly yours,
s/Richard S. Soroko
Richard S. Soroko